Procter & Gamble Beheer
Beheer criteriumcontroles 4/4
De CEO Procter & Gamble is Shailesh Jejurikar, benoemd in Jan2026, heeft een ambtstermijn van minder dan een jaar. De totale jaarlijkse vergoeding van { bedraagt $ 9.59M, bestaande uit 12.1% salaris en 87.9% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.004% van de aandelen van het bedrijf, ter waarde $ 12.40M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.6 jaar en 4.7 jaar.
Belangrijke informatie
Shailesh Jejurikar
Algemeen directeur
US$9.6m
Totale compensatie
| Percentage CEO-salaris | 12.12% |
| Dienstverband CEO | less than a year |
| Eigendom CEO | 0.004% |
| Management gemiddelde ambtstermijn | 3.6yrs |
| Gemiddelde ambtstermijn bestuur | 4.7yrs |
Recente managementupdates
Recent updates
Narratiefupdate • May 04
PG: Brand Partnerships And Product Pipeline Will Support Future Shareholder Returns
Analysts have trimmed their Procter & Gamble price target slightly to about $164.09, reflecting modestly lower assumptions for revenue and profit margins while applying a slightly higher future P/E outlook. What's in the News P&G maintained fiscal 2026 guidance, with all-in sales growth expected in a 1% to 5% range and diluted EPS growth targeted in a 1% to 6% range versus fiscal 2025 diluted EPS of US$6.51 (Corporate guidance).Seeking Alpha • Apr 25
Procter & Gamble: Fundamentals Are Solid, But The Price Is Too High - Downgrading From Buy To Hold
Summary Procter & Gamble is downgraded from buy to hold due to macroeconomic headwinds and valuation concerns. PG continues to deliver robust, broad-based organic sales growth of 3%, with strength in both volume and pricing. The company’s growth is well-diversified across regions and product categories, underscoring resilience despite poor consumer confidence. Current valuation does not adequately reflect heightened macro uncertainty, making a hold rating more justifiable at this time. Read the full article on Seeking Alpha
Nieuw narratief • Apr 24
Procter & Gamble (PG): The Beauty-Driven Beat and the Resilience of Staples
Procter & Gamble (PG) , the global vanguard of consumer staples, enters the afternoon of Friday, April 24, 2026 , as a beacon of stability following its Q3 Fiscal 2026 earnings report released this morning. The Cincinnati-based giant delivered a solid "beat-and-raise" performance, reporting Core EPS of $1.59 , surpassing the Wall Street consensus of $1.56.Narratiefupdate • Apr 20
PG: Buybacks And Brand Partnerships Will Support Future Shareholder Returns
Analysts have slightly reduced their price target on Procter & Gamble to $164.18 from $166.95, reflecting modestly lower assumptions for revenue growth, profit margins, fair value, and future P/E multiples. What's in the News P&G revised its fiscal 2026 diluted EPS growth outlook to a range of 1% to 6%, from a prior range of 3% to 9%, citing higher non core restructuring charges, while keeping all in sales growth guidance at 1% to 5% versus the prior year (Corporate guidance).Narratiefupdate • Apr 05
PG: Share Repurchases And Premium Portfolio Refresh Will Support Future Returns
Analysts have slightly reduced their average price target for Procter & Gamble to about $167 from $168, reflecting updated views on margins and forward P/E assumptions while keeping core growth expectations largely intact. What's in the News OLAY shared new skin aging research at the 2026 American Academy of Dermatology meeting, focusing on cell adhesion as a key factor in visible aging and applying these findings to peptide based products across the Regenerist line and the new Regenerist Treatments collection (Product announcement).Narratiefupdate • Mar 22
PG: Product Refresh And Buybacks Will Support Future Earnings Resilience
Analysts kept their Procter & Gamble price target steady at $168. This reflects largely unchanged views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions.Narratiefupdate • Mar 08
PG: Brand Refresh And Buybacks Will Support Stable Earnings Outlook
Analysts have maintained their Procter & Gamble price target at $168, reflecting unchanged assumptions around revenue growth, profit margins, and future P/E. This suggests that recent research has not materially shifted their valuation view.Narratiefupdate • Feb 21
PG: Brand Activity And Buybacks Will Support Stable Margins And Outlook
Analysts have nudged their price target for Procter & Gamble higher to $168.00 from $167.45, reflecting updated assumptions for revenue growth, slightly higher profit margins and a marginally lower future P/E multiple. What's in the News Tide launched Tide evo, a 100% concentrated, waterless laundry tile with six cleaning layers and no plastic bottles, positioned to address demand for products that align with hygiene and sustainability preferences in the U.S. (Product related announcement) Head & Shoulders introduced BARE Itchy Scalp Relief Serum, aimed at providing clinically tested dandruff protection and itch relief between washes, with a nationwide U.S. launch planned for January 2026.Narratiefupdate • Feb 07
PG: Premium Brand Extensions And Stable Margins Will Support A Balanced Outlook
Analysts have nudged their price target on Procter & Gamble slightly higher to US$167.45 from about US$165.32, reflecting updated assumptions for fair value, discount rate, revenue growth, profit margins and future P/E. What's in the News Old Spice launched the Spice Alchemist collection, a premium cologne-infused deodorant, body wash and body mist line positioned against high end fragrances.
Narratiefupdate • Jan 25
Q2 2026 Update
Update narrative with most recent financial statements.Narratiefupdate • Jan 23
PG: Share Repurchases And Margin Pressures Will Shape A Balanced Outlook
Analysts have trimmed their price target on Procter & Gamble to US$165 from US$168, citing updated views on revenue growth, profit margins, and the future P/E multiple. What's in the News P&G updated its fiscal 2026 guidance, keeping all in sales growth for the year in a range of 1% to 5% versus the prior year, while lowering the diluted EPS growth outlook to 1% to 6% from the previous 3% to 9% range, citing higher non core restructuring charges versus fiscal 2025 diluted EPS of US$6.51 (Corporate guidance).Narratiefupdate • Jan 07
PG: Share Repurchase Will Support Future Upside With Stable Long Term Outlook
Narrative Update on Procter & Gamble The analyst price target for Procter & Gamble has shifted slightly, with updated assumptions around fair value at about $168.13, discount rate at 6.96%, revenue growth at roughly 3.12%, profit margin near 19.58%, and future P/E around 26.08x, as analysts fine tune their models on the company. What's in the News Pantene is partnering again with social media creator Alix Earle to promote the Abundant & Strong 3-Step System, including limited-edition Alix x Pantene Kits that bundle the three products with a free cosmetics bag and hairbrush for a limited time (product-related announcement).Narratiefupdate • Dec 16
PG: Share Repurchase Will Support Future Upside Amid Stable Long Term Outlook
Analysts have nudged their price target for Procter & Gamble slightly lower to approximately $168.50 from about $169.05, reflecting modestly softer long term revenue growth expectations that are only partially offset by a marginally improved profit margin outlook and a slightly lower assumed future valuation multiple. What's in the News Pantene launched the Abundant & Strong Collection, a three step system clinically shown to reduce hair loss by up to 85% by targeting scalp oxidative stress with a Pro Vitamin Complex plus Niacinamide technology.Narratiefupdate • Dec 02
PG: Share Repurchase And New Collections Will Drive Continued Momentum
Procter & Gamble's analyst price target remains unchanged at $169.05 as analysts maintain stable estimates based on consistent fair value metrics and minimal adjustments to key financial assumptions. What's in the News Pantene launches the Abundant & Strong Collection, a new three-step system designed to reduce hair loss by up to 85% and promote stronger, denser hair using antioxidant technology.Narratiefupdate • Nov 18
PG: Share Buybacks And New Guidance Will Support Steady Uptrend
Analysts have maintained Procter & Gamble's price target at $169.05 per share. There have been only minor adjustments to underlying valuation factors, supporting a steady outlook for the company.Narratiefupdate • Nov 03
PG: Share Buyback And Product Rollout Will Drive Long-Term Upside
Analysts have slightly raised their price target for Procter & Gamble to $169.05 from $168.64. They cite incremental improvements in revenue growth forecasts even as profit margin projections moderate.Narratiefupdate • Oct 20
Rising Consumer Confidence And Product Investment Will Expand US Markets
Analysts have slightly lowered their price target for Procter & Gamble from $170.95 to $168.64 per share. They cite modest reductions in projected revenue growth, which are partially offset by improved profit margins and valuation multiples.Analyseartikel • Aug 06
The Procter & Gamble Company (NYSE:PG) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?
NYSE:PG 1 Year Share Price vs Fair Value Explore Procter & Gamble's Fair Values from the Community and select yours The...Nieuw narratief • Jul 21
Procter & Gamble: A Dividend Giant Facing Slowing Growth
United States: 48.21%1-Year Revenue Growth = 4.65%Analyseartikel • Jun 27
The Procter & Gamble Company (NYSE:PG) Shares Could Be 21% Below Their Intrinsic Value Estimate
Key Insights The projected fair value for Procter & Gamble is US$200 based on 2 Stage Free Cash Flow to Equity Procter...Seeking Alpha • Apr 22
Procter & Gamble: Hold This Stodgy Stalwart
Summary Procter & Gamble is a global consumer product leader, with a strong market presence and consistent, albeit slow, growth in revenue and earnings. Despite being overvalued, PG's profitability remains robust, with reliable cash flow and a solid gross profit margin above industry medians. PG's valuation poses a risk, with a high PEG ratio indicating slow growth, yet it maintains a decent dividend yield and outpaces peers in performance. PG is a safe investment but lacks excitement; it's a hold due to its steady but lethargic growth and overvaluation concerns. Read the full article on Seeking AlphaAnalyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | US$16b |
| Dec 31 2025 | n/a | n/a | US$16b |
| Sep 30 2025 | n/a | n/a | US$16b |
| Jun 30 2025 | US$10m | US$1m | US$16b |
| Mar 31 2025 | n/a | n/a | US$15b |
| Dec 31 2024 | n/a | n/a | US$15b |
| Sep 30 2024 | n/a | n/a | US$14b |
| Jun 30 2024 | US$10m | US$1m | US$15b |
| Mar 31 2024 | n/a | n/a | US$15b |
| Dec 31 2023 | n/a | n/a | US$14b |
| Sep 30 2023 | n/a | n/a | US$15b |
| Jun 30 2023 | US$8m | US$1m | US$14b |
| Mar 31 2023 | n/a | n/a | US$14b |
| Dec 31 2022 | n/a | n/a | US$14b |
| Sep 30 2022 | n/a | n/a | US$14b |
| Jun 30 2022 | US$7m | US$953k | US$14b |
| Mar 31 2022 | n/a | n/a | US$14b |
| Dec 31 2021 | n/a | n/a | US$14b |
| Sep 30 2021 | n/a | n/a | US$14b |
| Jun 30 2021 | US$6m | US$798k | US$14b |
Compensatie versus markt: De totale vergoeding ($USD 9.59M ) Shailesh } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 14.80M ).
Compensatie versus inkomsten: De vergoeding van Shailesh is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Shailesh Jejurikar (57 yo)
less than a year
Tenure
US$9,591,687
Compensatie
Mr. Shailesh G. Jejurikar was Independent Director at Otis Worldwide Corporation (also known as Otis Elevator Company, Inc) since April 03, 2020 until September 9, 2025. He serves as CEO & President at The...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Executive Chairman | 4.8yrs | US$21.91m | 0.016% $ 53.7m | |
| CEO, President & Director | less than a year | US$9.59m | 0.0038% $ 12.4m | |
| Chief Financial Officer | 5.2yrs | US$8.52m | 0.0026% $ 8.5m | |
| Chief Executive Officer of Health Care | 8.3yrs | US$6.04m | 0.0033% $ 10.9m | |
| Chief Executive Officer of Fabric and Home Care and P&G Ventures | 1.3yrs | US$7.18m | 0.0022% $ 7.1m | |
| Senior VP & Chief Accounting Officer | 3.8yrs | geen gegevens | 0.00018% $ 592.3k | |
| Chief Information Officer | 1.8yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Investor Relations | no data | geen gegevens | geen gegevens | |
| Chief Legal Officer & Secretary | 4.3yrs | geen gegevens | 0.0016% $ 5.2m | |
| Chief Communications Officer | 6.2yrs | geen gegevens | geen gegevens | |
| President of North America & Chief Sales Officer | no data | geen gegevens | geen gegevens | |
| Chief Human Resources Officer | 3.3yrs | US$7.48m | 0.00077% $ 2.5m |
3.6yrs
Gemiddelde duur
53.5yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van PG wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.6 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Executive Chairman | 4.8yrs | US$21.91m | 0.016% $ 53.7m | |
| CEO, President & Director | less than a year | US$9.59m | 0.0038% $ 12.4m | |
| Independent Director | 6.6yrs | US$370.00k | geen gegevens | |
| Independent Director | 5.8yrs | US$340.00k | geen gegevens | |
| Lead Independent Director | 8.2yrs | US$410.00k | 0.00054% $ 1.8m | |
| Independent Director | 3.6yrs | US$340.00k | geen gegevens | |
| Independent Director | 3.1yrs | US$340.00k | geen gegevens | |
| Independent Director | 2.6yrs | US$340.00k | geen gegevens | |
| Independent Director | 5.3yrs | US$340.00k | geen gegevens | |
| Independent Director | 8.9yrs | US$360.00k | geen gegevens | |
| Independent Director | 4.6yrs | US$340.00k | geen gegevens | |
| Independent Director | 3.1yrs | US$340.00k | geen gegevens |
4.7yrs
Gemiddelde duur
60yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van PG wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.7 jaar).
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/05/20 04:01 |
| Aandelenkoers aan het einde van de dag | 2026/05/20 00:00 |
| Inkomsten | 2026/03/31 |
| Jaarlijkse inkomsten | 2025/06/30 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
The Procter & Gamble Company wordt gevolgd door 43 analisten. 21 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Christopher Graja | Argus Research Company |
| Lauren Lieberman | Barclays |
| Lauren Lieberman | Barclays |